Source: VxP Pharma Blog

VxP Pharma Blog Injectable Biologic Formulation Has Developed Substantially in Recent Years, but Several Major Challenges Remain

Injectable biologics have some of the heaviest regulations of any pharmaceutical therapy. The US Food and Drug Administration (FDA) insists that anti-contamination protocols be followed throughout the manufacturing and packaging processes, with all personnel, equipment, and manufacturing and lab environments kept completely sterile. Compliance with good laboratory practices (GLP) and good manufacturing practices (GMP) is [...]The post Injectable Biologic Formulation Has Developed Substantially in Recent Years, but Several Major Challenges Remain appeared first on VxP Pharma.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Ray Peck's photo - CEO of VxP Pharma

CEO

Ray Peck

CEO Approval Rating

90/100



VxP Pharma's headquarters is in Indianapolis, Indiana. VxP Pharma has a revenue of $10M, and 60 employees. VxP Pharma has 3 followers on Owler.